Met Life Investment Management, LLC Orasure Technologies Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Orasure Technologies Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 48,542 shares of OSUR stock, worth $176,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,542
Previous 48,542 -0.0%
Holding current value
$176,692
Previous $206,000 0.49%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$4.2 - $6.18 $22,066 - $32,469
5,254 Added 12.14%
48,542 $206,000
Q1 2024

May 14, 2024
BUY
$6.08 - $8.28 $263,191 - $358,424
43,288 New
43,288 $266,000
Q2 2023

Apr 29, 2024
BUY
$4.88 - $7.39 $211,245 - $319,898
43,288 New
43,288 $216,000
Q1 2023

May 09, 2024
BUY
$4.66 - $6.52 $201,722 - $282,237
43,288 New
43,288 $262 Million
Q1 2022

May 10, 2024
BUY
$6.62 - $9.33 $286,566 - $403,877
43,288 New
43,288 $293,000
Q1 2022

Mar 22, 2023
BUY
$6.62 - $9.33 $97,002 - $136,712
14,653 Added 51.17%
43,288 $293,000
Q1 2022

May 12, 2022
BUY
$6.62 - $9.33 $97,002 - $136,712
14,653 Added 51.17%
43,288 $293,000
Q4 2021

Jun 21, 2023
SELL
$8.3 - $11.29 $121,619 - $165,432
-14,653 Reduced 33.85%
28,635 $248,000
Q3 2021

Jun 21, 2023
SELL
$9.73 - $13.38 $142,573 - $196,057
-14,653 Reduced 33.85%
28,635 $323,000
Q2 2021

Jun 21, 2023
SELL
$9.02 - $11.68 $132,170 - $171,147
-14,653 Reduced 33.85%
28,635 $290,000
Q1 2021

May 17, 2024
SELL
$9.53 - $15.42 $139,643 - $225,949
-14,653 Reduced 33.85%
28,635 $334,000
Q1 2021

Jun 26, 2023
SELL
$9.53 - $15.42 $139,643 - $225,949
-14,653 Reduced 33.85%
28,635 $334 Million
Q1 2021

Mar 22, 2023
BUY
$9.53 - $15.42 $1,801 - $2,914
189 Added 0.66%
28,635 $334,000
Q1 2021

May 14, 2021
BUY
$9.53 - $15.42 $1,801 - $2,914
189 Added 0.66%
28,635 $334,000
Q4 2020

Jun 22, 2023
SELL
$10.35 - $15.94 $153,614 - $236,581
-14,842 Reduced 34.29%
28,446 $301,000
Q3 2020

Jun 26, 2023
SELL
$10.24 - $19.58 $151,982 - $290,606
-14,842 Reduced 34.29%
28,446 $346,000
Q2 2020

May 24, 2024
SELL
$9.71 - $17.87 $144,115 - $265,226
-14,842 Reduced 34.29%
28,446 $331 Million
Q2 2020

Jun 26, 2023
SELL
$9.71 - $17.87 $144,115 - $265,226
-14,842 Reduced 34.29%
28,446 $330,000
Q1 2020

Jul 12, 2023
SELL
$5.57 - $10.76 $82,669 - $159,699
-14,842 Reduced 34.29%
28,446 $306,000
Q4 2019

Jul 12, 2023
SELL
$7.21 - $8.89 $107,010 - $131,945
-14,842 Reduced 34.29%
28,446 $228,000
Q3 2019

Jul 12, 2023
SELL
$6.57 - $9.46 $97,511 - $140,405
-14,842 Reduced 34.29%
28,446 $212,000
Q2 2019

Jul 12, 2023
SELL
$8.17 - $11.07 $121,259 - $164,300
-14,842 Reduced 34.29%
28,446 $263,000
Q1 2019

Jul 13, 2023
SELL
$9.63 - $13.09 $142,928 - $194,281
-14,842 Reduced 34.29%
28,446 $317,000
Q4 2018

Jul 13, 2023
SELL
$10.53 - $15.54 $156,286 - $230,644
-14,842 Reduced 34.29%
28,446 $332,000
Q4 2018

Mar 22, 2023
SELL
$10.53 - $15.54 $151,600 - $223,729
-14,397 Reduced 33.6%
28,446 $332,000
Q4 2018

Feb 14, 2019
SELL
$10.53 - $15.54 $151,600 - $223,729
-14,397 Reduced 33.6%
28,446 $332,000
Q3 2018

Jul 13, 2023
SELL
$15.25 - $17.72 $226,340 - $263,000
-14,842 Reduced 34.29%
28,446 $439,000
Q3 2018

Mar 22, 2023
SELL
$15.25 - $17.72 $6,786 - $7,885
-445 Reduced 1.03%
42,843 $661,000
Q3 2018

Nov 14, 2018
BUY
$15.25 - $17.72 $219,554 - $255,114
14,397 Added 50.61%
42,843 $662,000
Q2 2018

Aug 15, 2018
BUY
$14.46 - $18.08 $49,626 - $62,050
3,432 Added 13.72%
28,446 $469,000
Q4 2017

Feb 15, 2018
BUY
$13.44 - $22.81 $336,188 - $570,569
25,014
25,014 $472,000

Others Institutions Holding OSUR

# of Institutions
201
Shares Held
65.4M
Call Options Held
2.2K
Put Options Held
5.1K
View Full List

About ORASURE TECHNOLOGIES INC

OSUR Quotes by TradingView
  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $264M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email